1.Association of Insulin Resistance with Overactive Bladder in Female Patients.
Hakki UZUN ; Adnan YILMAZ ; Ahu KEMIK ; Orhan Unal ZORBA ; Mehmet KALKAN
International Neurourology Journal 2012;16(4):181-186
PURPOSE: Metabolic syndrome and obesity have been advocated to be risk factors for the development of overactive bladder (OAB). Additionally, insulin resistance is the underlying mechanism of metabolic syndrome. We aimed to investigate the association of insulin resistance with overactive bladder in female patients. METHODS: We prospectively conducted the study in our urology department. Female patients aged between 30 and 76 years old applied to our policlinics with or without OAB symptoms were enrolled. One hundred and twenty-two patients with OAB and 62 age-matched controls without OAB were included into the study. Fasting serum insulin, glucose, high-density lipoprotein (HDL-c), and triglycerides levels were measured. Insulin resistance value was obtained via the homeostasis model assessment of insulin resistance (HOMA-IR) calculator. The chi-square and Mann-Whitney U tests were used to compare differences in variables. RESULTS: Serum insulin level was found higher in female patients with OAB (11.5+/-6.2 microU/mL) relative to controls (6.4+/-2.1 microU/mL), statistically significant (P=0.036). In addition, HOMA-IR was significantly found higher in the OAB group, 2.86 (0.76 to 17.04) in comparison to controls, 1.32 (0.67 to 224), P=0.018. High-density lipoprotein cholesterol levels (HDL-c) were significantly found lower in females with OAB. CONCLUSIONS: Insulin resistance can be associated to overactive bladder and may play significant role in pathogenesis.
Aged
;
Cholesterol
;
Fasting
;
Female
;
Glucose
;
Homeostasis
;
Humans
;
Insulin
;
Insulin Resistance
;
Lipoproteins
;
Obesity
;
Prospective Studies
;
Risk Factors
;
Triglycerides
;
Urinary Bladder, Overactive
;
Urology
2.Increased Bladder Wall Thickness in Diabetic and Nondiabetic Women With Overactive Bladder.
Hakki UZUN ; Sabri OGULLAR ; Serap Baydur SAHIN ; Orhan Unal ZORBA ; Gorkem AKCA ; Fatih SUMER ; Ulku Mete GUNEY ; Gulsah BALIK
International Neurourology Journal 2013;17(2):67-72
PURPOSE: Bladder wall thickness has been reported to be associated with overactive bladder (OAB) in women. Diabetic women have an increased risk for OAB syndrome and may have an increased risk for bladder wall thickness. METHODS: A total of 235 female patients aged 40 to 75 years were categorized into four groups. The first group consisted of women free of urgency or urge urinary incontinence. The second group included nondiabetic women with idiopathic OAB. The third group consisted of women with diabetes and clinical OAB, and women with diabetes but without OAB constituted the fourth group. Bladder wall thickness at the anterior wall was measured by ultrasound by the suprapubic approach with bladder filling over 250 mL. RESULTS: The diabetic (third group) and nondiabetic (second group) women with OAB had significantly greater bladder wall thickness at the anterior bladder wall than did the controls. However, the difference was not significant between the diabetic (third group) and the nondiabetic (second group) women with OAB. Women with diabetes but without OAB (fourth group) had greater bladder wall thickness than did the controls but this difference was not significant. Additionally, the difference in bladder wall thickness between diabetic women with (third group) and without (fourth group) OAB was not significant. CONCLUSIONS: This is the first study to show that bladder wall thickness is increased in diabetic women with and without OAB. Additionally, nondiabetic women with OAB had increased bladder wall thickness. Further studies may provide additional information for diabetic and nondiabetic women with OAB, in whom the etiopathogenesis of the disease may be similar.
Aged
;
Diabetes Mellitus
;
Female
;
Humans
;
Urinary Bladder
;
Urinary Bladder, Overactive
;
Urinary Incontinence
3.In Vitro Effects of Rabeprazole on Human Pylorus Tone.
Necdet Fatih YASAR ; Erdal POLAT ; Mustafa DUMAN ; Meltem DAGDELEN ; Mehmet Yalcin GUNAL ; Orhan UZUN ; Cebrail AKYUZ ; Kivanc Derya PEKER ; Sinan YOL
Journal of Neurogastroenterology and Motility 2015;21(2):217-221
BACKGROUND/AIMS: It has been reported that proton pump inhibitors induce relaxation in different types of smooth muscles. The aim of this study is to investigate in vitro effects of proton pump inhibitors on human pylorus muscle. METHODS: Pyloric sphincters were studied in 10 patients who were operated for stomach cancer. In isolated organ bath, control and response to rabeprazole were recorded following contraction with carbachol. During the treatment experiment, while distilled water was applied during the control experiment in every 5 minutes, rabeprazole was administered in every 5 minutes at doses of 10-6, 10-5, 10-4, and 10-3 M respectively. Contraction frequencies, maximum contraction values and muscle tones were measured. RESULTS: The contraction frequencies in the control group were greater than the rabeprazole group in the second, third and fourth intervals while the maximum contraction values in the rabeprazole group were lower in the fourth interval. Even though muscles tones were not different in both groups during all intervals, it was remarkable that the muscle tone was significantly decreased in the rabeprazole group during the fourth interval compared to the first and second intervals. CONCLUSIONS: In the present study, high doses of rabeprazole reduced contraction frequencies, maximum contraction values, and muscle tone of human pylorus.
Baths
;
Carbachol
;
Humans
;
Muscle Tonus
;
Muscle, Smooth
;
Muscles
;
Proton Pump Inhibitors
;
Pylorus*
;
Rabeprazole*
;
Relaxation
;
Stomach Neoplasms
;
Water
4.Effects of melatonin on colonic anastomosis healing following chemotherapy in rats.
Cebrail AKYUZ ; Necdet Fatih YASAR ; Orhan UZUN ; Kıvanc Derya PEKER ; Oguzhan SUNAMAK ; Mustafa DUMAN ; Ahmet Ozer SEHIRLI ; Sinan YOL
Singapore medical journal 2018;59(10):545-549
INTRODUCTIONThis study aimed to investigate the effects of melatonin on the healing of colon anastomosis following chemotherapy.
METHODS32 rats were randomised into four groups: (a) control group, which underwent sigmoid colon transection and primary anastomosis; (b) melatonin group, which received melatonin daily following anastomosis; (c) 5-fluorouracil (5-FU) group, which received 5-FU for five days prior to anastomosis; and (d) 5-FU+melatonin group, which received 5-FU for five days prior to anastomosis and melatonin daily following anastomosis. The rats were sacrificed on Postoperative Day 7 and anastomotic bursting pressures were measured. The anastomotic segment was extracted for hydroxyproline, luminol and lucigenin measurement and histopathological examination. Blood samples were obtained from the vena cava for measurement of tumour necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β) plasma levels.
RESULTSCompared to the 5-FU group, bursting pressures of anastomosis and hydroxyproline levels were significantly higher, while luminol and lucigenin levels were significantly lower, in the control and 5-FU+melatonin groups. In addition, TNF-α and IL-1β plasma levels were significantly lower in the control and 5-FU+melatonin groups than in the 5-FU group. Histopathological examination showed a significant decrease in inflammation and necrosis formation in the melatonin group when compared to the control group. The positive effect of melatonin was also seen in the rats that received 5-FU.
CONCLUSIONOur study results showed that the adverse effects of chemotherapy on the mechanical, biochemical and histopathological parameters of anastomosis healing were attenuated through melatonin treatment.